Skip Navigation


PEDS Advance Access originally published online on July 12, 2009
Protein Engineering Design and Selection 2009 22(8):497-513; doi:10.1093/protein/gzp029
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
22/8/497    most recent
gzp029v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cort, J. R.
Right arrow Articles by Andersen, N. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cort, J. R.
Right arrow Articles by Andersen, N. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

This article appears in the following Protein Engineering issue: Amyloids Special Issue [View the issue table of contents]

Solution state structures of human pancreatic amylin and pramlintide

John R. Cort1, Zhihong Liu1, Gregory M. Lee1, K.N.L. Huggins1, Susan Janes2, Kathryn Prickett2 and Niels H. Andersen1,3

1Department of Chemistry, University of Washington, Seattle, WA 98195, USA 2Amylin Pharmaceuticals, 9373 Towne Centre Dr., San Diego, CA 92121, USA

3 To whom correspondence should be addressed. E-mail: andersen{at}chem.washington.edu

We have employed pramlintide (prAM) as a surrogate for hAM in CD and NMR studies of the conformational preferences of the N-terminal portion of the structure in media which do not provide long-lived monomeric solutions of hAM due to its rapid conversion to preamyloid β aggregate states. Direct comparison of hAM and prAM could be made under helix-formation-favoring conditions. On the basis of CD and NMR studies: (i) the Cys2–Cys7 loop conformation has a short-span of helix (Ala5–Cys7); (ii) the extent to which this helix propagates further into the sequence is medium-dependent; a helix from Ala5 through Ser20 (with end fraying from His18 onward) is observed in aqueous fluoroalcohol media; (iii) in 12+ vol.% HFIP, the amyloidogenic region of hAM forms a second helical domain (Phe23–Ser29); (iv) the two helical regions of hAM do not have any specific geometric relationship as they are connected by a flexible loop that takes different conformations and (v) although the extreme C-terminus is essential for bioactivity, it is found to be extensively randomized with conformer interconversions occurring at a much faster rate than that is observed in the remainder of the peptide sequence. Two NMR-derived structures of the 1–22 sequence fragment of hAM have been derived. The work also serves to illustrate improved methods for the NMR characterization of helices. A detailed quantitative analysis of the NOE intensities observed in aqueous HFIP revealed alternative conformations in the C-terminal portion of the common amylin helix, a region that is known to be involved in the biorecognition phenomena leading to amyloidogenesis. Even though the SNN sequence appears to be a flexible loop, the chemical shifts (and changes induced upon helix structuring) suggest some interactions between the loop and the amyloidogenic segment of hAM that occur on partial helix formation.

Keywords: amyloidogenesis/CD spectroscopy/chemical shift deviations/helix formation/NMR

Received June 1, 2009; revised June 1, 2009; accepted June 3, 2009.


Abbreviations: ADCs, anti-distance constraints are designated as low-bounds-only (LBO) constraints herein; CD, circular dichroism or dichroic; CSD, chemical shift deviation; CGRP, calcitonin gene-related peptide; DCs, distance constraints, these are indicated without the hydrogen designation as {alpha}iNi+3, which corresponds to the distance or NOE intensity between H{alpha} of residue i and HN of residue i + 3; DMSO, dimethyl sulfoxide; GdmCl, guanidinium chloride; hAM, human pancreatic amylin (likewise, rAM is rat amylin); HFIP, hexafluoroisopropanol; NOE, Nuclear Overhauser Effect; R1 = [{theta}]max or [{theta}]191/[{theta}]min, a ratio of CD ellipticities in the 225–190 nm span; R2 = [{theta}]221/[{theta}]min, a ratio of CD ellipticities in the 225–195 nm span; SA, simulated annealing; SDS, sodium dodecyl sulfonate; TFA, trifluoroacetic acid; TFE, β,β,β-trifluoroethanol; the usual one and three letter abbreviation for the natural amino acids are used without definition as are the acronyms for NMR experiments: COSY, HSQC, HMQC, NOESY, RELAY, ROESY and TOCSY.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.